Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9226773 | Journal of Allergy and Clinical Immunology | 2005 | 7 Pages |
Abstract
The treatment of asthma with systemic corticosteroids resulted in a deficit of about 200 g in birth weight compared with controls and exclusive β2-agonist users and no increased incidence of SGA. These results suggest that asthma management with β2-agonists and/or inhaled corticosteroids during pregnancy does not impair fetal growth, whereas systemic corticosteroids have a minimal effect which should be weighed against the necessity to control severe asthma.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ludmila N. MD, MPH, Kenneth Lyons MD, Michael MD, MS, Diana MS, Christina D. PhD, MPH, the Organization of Teratology Information Services Research Group the Organization of Teratology Information Services Research Group,